Vident Investment Advisory LLC lifted its stake in shares of Perrigo Company (NYSE:PRGO) by 365.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,454 shares of the company’s stock after purchasing an additional 14,492 shares during the period. Vident Investment Advisory LLC’s holdings in Perrigo were worth $1,562,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in the company. Asset Management One Co. Ltd. raised its stake in shares of Perrigo by 5,856.9% during the 3rd quarter. Asset Management One Co. Ltd. now owns 190,501 shares of the company’s stock worth $16,126,000 after purchasing an additional 187,303 shares in the last quarter. Allianz Asset Management GmbH bought a new stake in shares of Perrigo during the 3rd quarter worth approximately $217,000. Nomura Asset Management Co. Ltd. raised its stake in shares of Perrigo by 4.3% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 18,350 shares of the company’s stock worth $1,553,000 after purchasing an additional 749 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Perrigo by 6.4% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 18,221 shares of the company’s stock worth $1,549,000 after purchasing an additional 1,100 shares in the last quarter. Finally, Engineers Gate Manager LP raised its stake in shares of Perrigo by 88.3% during the 3rd quarter. Engineers Gate Manager LP now owns 17,743 shares of the company’s stock worth $1,502,000 after purchasing an additional 8,319 shares in the last quarter. Institutional investors own 85.53% of the company’s stock.
Perrigo Company (NYSE PRGO) traded up $0.10 on Thursday, reaching $86.02. The company had a trading volume of 1,106,400 shares, compared to its average volume of 1,683,894. Perrigo Company has a twelve month low of $63.68 and a twelve month high of $91.73. The company has a current ratio of 1.72, a quick ratio of 1.24 and a debt-to-equity ratio of 0.54. The company has a market cap of $12,101.03, a PE ratio of 17.53, a PEG ratio of 1.83 and a beta of 0.70.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 19th. Shareholders of record on Friday, December 1st will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Thursday, November 30th. Perrigo’s dividend payout ratio is -6.99%.
In other Perrigo news, EVP John Wesolowski sold 450 shares of the company’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $83.09, for a total value of $37,390.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Over the last ninety days, insiders sold 1,051 shares of company stock worth $89,810. Insiders own 6.90% of the company’s stock.
A number of equities research analysts have recently issued reports on PRGO shares. Deutsche Bank upped their price objective on Perrigo from $88.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, September 14th. Cantor Fitzgerald reiterated a “buy” rating on shares of Perrigo in a research note on Monday, August 21st. Canaccord Genuity reiterated a “buy” rating and set a $100.00 price objective (up previously from $88.00) on shares of Perrigo in a research note on Wednesday, September 13th. UBS reiterated a “buy” rating and set a $98.00 price objective (up previously from $84.00) on shares of Perrigo in a research note on Thursday, October 5th. Finally, Oppenheimer started coverage on Perrigo in a research note on Monday, October 2nd. They set a “buy” rating and a $88.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $92.13.
COPYRIGHT VIOLATION WARNING: “Vident Investment Advisory LLC Grows Holdings in Perrigo Company (PRGO)” was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/14/vident-investment-advisory-llc-grows-holdings-in-perrigo-company-prgo.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).
What are top analysts saying about Perrigo? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Perrigo and related companies.